Lacidipine

DRUG7 trials

Sponsors

GlaxoSmithKline, Boehringer Ingelheim

Conditions

Diabetes Mellitus, Type 2Essential HypertensionHealthyHypertension

Phase 1

Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects

CompletedNCT02203500

Boehringer IngelheimHealthy

Start: 1998-10-31Updated: 2014-08-06

Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

CompletedNCT02209649

Boehringer IngelheimHealthy

Start: 1999-10-31Updated: 2014-08-06

Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects

CompletedNCT02218684

Boehringer IngelheimHealthy

Start: 1998-09-30Updated: 2014-08-18

Phase 3

Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension

CompletedNCT02177331

Boehringer IngelheimHypertension

Start: 1995-06-30Updated: 2014-07-14

Phase 4

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

CompletedNCT00328965

GlaxoSmithKlineDiabetes Mellitus, Type 2, Essential Hypertension

Start: 2004-11-30End: 2006-05-31Updated: 2010-08-16

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

CompletedNCT02235402

Boehringer IngelheimHypertension

Start: 1997-12-31Updated: 2014-09-10

Unknown Phase

Effect of Caldine® on Renal Function in Balanced Hypertension

TerminatedNCT02240641

Boehringer IngelheimHypertension

Start: 1998-05-31Updated: 2014-09-16

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01